+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biochips Market Research Report by Fabrication Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4857855
  • Report
  • June 2020
  • Region: Global
  • 214 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Biochips Market to Grow USD 75,809.26 Million by 2025, at a CAGR of 20.14%

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MORE
The Global Biochips Market is expected to grow from USD 25,201.56 Million in 2019 to USD 75,809.26 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 20.14%.

Market Segmentation & Coverage:

This research report categorizes the Biochips to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Fabrication Technology, the Biochips Market is examined across Microarrays and Microfluidics.

On the basis of Type, the Biochips Market is examined across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays further studied across Cell Arrays and Tissue Arrays.

On the basis of Application, the Biochips Market is examined across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, DNA Chip Applications, Diagnostics, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping.

On the basis of End User, the Biochips Market is examined across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.

On the basis of Geography, the Biochips Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biochips Market including Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corporation, GE Healthcare, Illumina, Inc., Perkinelmer, Inc., Roche Diagnostics, and Thermo Fisher Scientific, Inc..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biochips Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biochips Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biochips Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biochips Market?
4. What is the competitive strategic window for opportunities in the Global Biochips Market?
5. What are the technology trends and regulatory frameworks in the Global Biochips Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biochips Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window

3. Executive Summary
3.1. Market Outlook
3.2. Fabrication Technology Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Biochips Market, By Geography

5. Market Dynamics
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
5.1.1.2. Demand of personalized adoption owing to increase adoption
5.1.1.3. Large number of biochips applications
5.1.2. Restraints
5.1.2.1. Limited awareness in developing economies
5.1.2.2. Loosely defined regulatory guidelines
5.1.3. Opportunities
5.1.3.1. Potential in untapped developed regions
5.1.3.2. Safe and economical alternative to animal testing
5.1.4. Challenges
5.1.4.1. High cost associated with biochips
5.1.4.2. Complexity associated with the biological system

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
6.3.1. Technology Advancements
6.3.2. Impact Analysis

7. Global Biochips Market, By Fabrication Technology
7.1. Introduction
7.2. Microarrays
7.3. Microfluidics

8. Global Biochips Market, By Type
8.1. Introduction
8.2. Arrays
8.2.1. Cell Arrays
8.2.2. Tissue Arrays
8.3. DNA Chips
8.4. Lab-On-A-Chip
8.5. Protein Chips

9. Global Biochips Market, By Application
9.1. Introduction
9.2. Agricultural Biotechnology
9.3. Cancer Diagnosis & Treatment
9.4. Clinical Diagnostics
9.5. DNA Chip Applications
9.6. Diagnostics
9.7. Drug Discovery
9.8. Expression Profiling
9.9. Gene Expression
9.10. Genomics
9.11. High-Throughput Screening
9.12. IVD & POC
9.13. Proteomics
9.14. SNP Genotyping

10. Global Biochips Market, By End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Hospitals & Diagnostics Centers

11. Americas Biochips Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Biochips Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand

13. Europe, Middle East & Africa Biochips Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding

15. Company Usability Profiles
15.1. Abbott Laboratories
15.2. Agilent Technologies, Inc.
15.3. Bio-Rad Laboratories Inc.
15.4. Cepheid Inc.
15.5. Fluidigm Corporation
15.6. GE Healthcare
15.7. Illumina, Inc.
15.8. Perkinelmer, Inc.
15.9. Roche Diagnostics
15.10. Thermo Fisher Scientific, Inc.

16. Appendix
16.1. Discussion Guide
16.2. Edition Details
16.3. License Details
16.4. Pricing Details
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll